DAVIS, Calif., Sept. 9, 2020 /PRNewswire/ -- Arcadia
Biosciences, Inc.® (Nasdaq: RKDA), a leader in
science-based approaches to enhancing the quality and nutritional
value of crops and food ingredients, announced today that it will
be featured as a presenting company at the 22nd Annual
Global Investment Conference sponsored by H.C Wainwright. The
conference is being held virtually on September 14-16, 2020.
Matthew Plavan, Arcadia's president and CEO will present a
business overview at 2:00 p.m. EDT on Wednesday, September 16, 2020 and will be
available for one-on-one web meetings with investors. Institutional
investors may request a meeting by registering for the conference
at www.hccwevents.com.
The presentation will be webcast live here, and a replay will be
available in the Investors section of the company's website.
About Arcadia Biosciences
Arcadia Biosciences (Nasdaq:
RKDA) is a leader in science-based approaches to enhancing the
quality and nutritional value of crops and food ingredients. The
company's GoodHempTM seed catalog delivers
genetically superior hemp seeds, clones, transplants and extracts,
applying the company's proprietary crop innovation technology,
ArcaTech™, to an emerging crop. The company's GoodWheat™ branded
ingredients deliver health benefits to consumers and enable
consumer packaged goods companies to differentiate their brands in
the marketplace. Arcadia's
agricultural traits are being developed to enable farmers around
the world to be more productive and minimize the impact of
agriculture on the environment. For more information,
visit www.arcadiabio.com.
LinkedIn: Arcadia Biosciences
Twitter: @ArcadiaAg
View original content to download
multimedia:http://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-to-present-at-hc-wainwrights-22nd-annual-global-investment-conference-september-14-16-2020-301126240.html
SOURCE Arcadia Biosciences, Inc.